Cargando…

The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM‐CHF randomized controlled trial

AIMS: Patients with heart failure (HF) have impaired quality of life (QoL). The randomized controlled trial PHARM‐CHF investigated whether an interdisciplinary intervention consisting of regular contacts with the community pharmacy and weekly dosing aids improves medication adherence in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulz, Martin, Griese‐Mammen, Nina, Schumacher, Pia M., Anker, Stefan D., Koehler, Friedrich, Ruckes, Christian, Rettig‐Ewen, Volker, Wachter, Rolf, Trenk, Dietmar, Böhm, Michael, Laufs, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754956/ https://www.ncbi.nlm.nih.gov/pubmed/32700409 http://dx.doi.org/10.1002/ehf2.12904

Ejemplares similares

Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial
por: Schumacher, Pia M., et al.
Publicado: (2021)

Development and implementation of blood pressure screening and referral guidelines for German community pharmacists
por: Schulz, Martin, et al.
Publicado: (2020)

The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta‐analysis
por: Schumacher, Pia M., et al.
Publicado: (2021)

Heart failure patients with atrial fibrillation benefit from remote patient management: insights from the TIM‐HF2 trial
por: Stegmann, Tina, et al.
Publicado: (2020)

Primary healthcare policy and vision for community pharmacy and pharmacists in Germany
por: Eickhoff, Christiane, et al.
Publicado: (2021)

The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica
por: Gossell-Williams, Maxine, et al.
Publicado: (2008)

Early detection of atrial fibrillation in patients with heart failure reduces the risk of subsequent hospitalization: a subanalysis of the randomized TIM-HF2 trial
por: Stegmann, Tina, et al.
Publicado: (2022)

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
por: Hashemi, Djawid, et al.
Publicado: (2022)

PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study
por: Rech, Megan A., et al.
Publicado: (2021)

Fat pharms.
por: Ma, M
Publicado: (1996)

The technology of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure
por: Ihle, Peter, et al.
Publicado: (2019)

Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
por: Eidizadeh, Abass, et al.
Publicado: (2022)

PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study
por: Rech, Megan A., et al.
Publicado: (2021)

Cardiovascular drug interventions in the cardio-oncology clinic by a cardiology pharmacist: ICOP-Pharm study
por: Yaseen, Israa Fadhil, et al.
Publicado: (2022)

Pharmacist Avoidance or Reductions in Medical Costs in Critically and Emergently Ill Pediatrics: PHARM-PEDS Study
por: Kiskaddon, Amy L., et al.
Publicado: (2023)

The Evolution of PharmVar
por: Gaedigk, Andrea, et al.
Publicado: (2018)

Legal problems of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Process Evaluation of the Community Pharmacist-Led Allergic Rhinitis Management (C-PhARM) Service in Singapore
por: Yap, Joanne Shi Ying, et al.
Publicado: (2019)

Impact of Pharmacist-Led Heart Failure Clinic on Optimization of Guideline-Directed Medical Therapy (PHARM-HF)
por: Patil, Tanvi, et al.
Publicado: (2022)

Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm)
por: Scala, Daniela, et al.
Publicado: (2022)

A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework
por: Murry, Logan T., et al.
Publicado: (2022)

ECOLOGY AND WILDLIFE: Pharmed Fish
por: Betts, Kellyn S.
Publicado: (2009)

Synthesis of CHF(2)-substituted 3-azabicyclo[3.1.0]hexanes by photochemical decomposition of CHF(2)-pyrazolines
por: Zheng, Yang, et al.
Publicado: (2018)

“Pharming out” support: a promising approach to integrating clinical pharmacists into established primary care medical home practices
por: Brunisholz, Kimberly D., et al.
Publicado: (2017)

Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain
por: Schulz, Martin, et al.
Publicado: (2022)

Medication knowledge of patients hospitalized for heart failure at admission and after discharge
por: Custodis, Florian, et al.
Publicado: (2016)

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study
por: Stahrenberg, Raoul, et al.
Publicado: (2015)

The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021)

Efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients, a randomized controlled trial - “Pharm-MD”: Impact of clinical pharmacists in diabetes care
por: Halalau, Alexandra, et al.
Publicado: (2022)

PharmGED: Pharmacogenetic Effect Database
por: Zheng, C. J., et al.
Publicado: (2007)

Cell Engineering and Molecular Pharming for Biopharmaceuticals
por: Abdullah, M.A, et al.
Publicado: (2008)

Introduction of APCs in J. Young Pharm.
por: Mueen, Ahmed KK
Publicado: (2012)

My Vision: J Young Pharm
por: Parasuraman, S
Publicado: (2012)

A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study
por: Farley, Amanda, et al.
Publicado: (2017)

Reading Level and Suitability of Congestive Heart Failure (CHF) Education in a Mobile App (CHF Info App): Descriptive Design Study
por: Athilingam, Ponrathi, et al.
Publicado: (2019)

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015)

Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT‐CHF
por: Pagnesi, Matteo, et al.
Publicado: (2021)

Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
por: Abdin, Amr, et al.
Publicado: (2022)

Erratum to: A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study
por: Farley, Amanda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iu1ugoialuq32v88h1s5au1o7p